December 16, 2013 | Hadasit, the technology transfer company of the Hadassah Medical Center, has signed a $4 million cooperation agreement with Poland’s Synektik SA to develop new imaging agents for non-invasive diagnosis of cardiovascular disease. The imaging agents are for use in PET/ CT scans, enabling physicians to achieve a quantitative measurement of blood flow to the heart.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Startup Helps Doctors Analyze Heart Scans
February 08, 2023

AI Monitors High-Speed Conveyor Belts For Defects
February 08, 2023

Israel Hi-Tech Group In Rescue Mission To Turkey
February 08, 2023

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023
Facebook comments